pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Oncology · news · pharmadog
← back to Oncology
News · Oncology
1,493
stories
20d
Ultragenyx prices Sanfilippo gene therapy at $4M; Bristol Myers shelves Orum drug
biopharma dive
20d
Xenon tumbles on voluntary psychiatry hold, but analysts confident in $2B epilepsy opportunity
biospace
20d
STAT+: Roche expands its Boston footprint with new research center
stat
21d
BMS scraps Orum’s targeted degrader after reviewing Phase 1 data
biospace
21d
Who supports policies for ‘health equity’? It depends on how you’re asking
stat
21d
In Sudan, attacks on hospitals force patients to make dangerous journeys
stat
21d
Opinion: More young men are coming to me for plastic surgery. The way I think about them has changed
stat
21d
Opinion: Doctors should educate patients about ‘Asian glow’ and drinking risks
stat
21d
BMS dumps $100M Orum degrader-antibody conjugate after glimpsing phase 1 data
fiercebiotech
21d
Inflammation biotech Electra charges up with $350M from upsized IPO
fiercebiotech
21d
Electra amasses $350M in biotech’s latest big IPO
biopharma dive
21d
Bristol Myers scraps $100M Orum-partnered cancer drug
endpoints
21d
FDA Approves First Gene Therapy for Pediatric Patients with Sanfilippo Syndrome Type A
fda press
21d
STAT+: Why do ‘never-smokers’ get lung cancer? In some cases, rare genetic variant may be a factor
stat
21d
Novo notches up to $1.4B pact with Orbis to develop oral macrocycle cardiometabolic drugs
biospace
21d
Chutes & Ladders—Legend poaches Novartis vet to boost commercial potential
fiercebiotech
21d
Kennedy moves to revive preventive services panel with new members, after months of vacancies
stat
21d
Roche eyes label expansion for Lunsumio after confirmatory lymphoma trial win
endpoints
22d
Roche bets up to $1B to advance next-gen bispecifics with Dualitas
biospace
22d
DPHARM: How to address the clinical trial enrollment crisis?
fiercebiotech
22d
STAT+: A Sellas immunotherapy study, long delayed, will end in failure
stat
22d
After one failed acquisition attempt, Lisata finds lifeline in Marea merger
fiercebiotech
22d
Roche, Dualitas team up to find bispecific drugs for immune diseases
biopharma dive
22d
Rare EGFR mutation increases lung cancer risk 62 times in never smokers
fiercebiotech
22d
Opinion: What happened to oppositional defiant disorder?
stat
22d
Roche signs $1B deal with Dualitas to pair up on big bispecific screening drive
fiercebiotech
22d
STAT+: England to cover AstraZeneca breast cancer drug, a result of U.K.-U.S. drug pricing deal
stat
22d
Biopharma hiring hotspots: States, disciplines where demand is highest
biospace
22d
STAT+: Scientists made mice with half a brain. Then they filled them with human organoids
stat
22d
Sling banks $123M for an experimental thyroid eye disease pill
biopharma dive
← prev
page 8 of 50
next →
